Aviva PLC Penumbra Inc Transaction History

Aviva PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$235.0 - $310.7 $1.07 Million - $1.41 Million	-4,534 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$175.6 - $291.43 $286,403 - $475,322	-1,631 Reduced 26.46%	4,534 $1.23 Million
Q4 2020 Feb 10, 2021	SELL	$174.98 - $272.83 $874,375 - $1.36 Million	-4,997 Reduced 44.77%	6,165 $1.08 Million
Q3 2020 Nov 12, 2020	SELL	$185.27 - $238.73 $386,658 - $498,229	-2,087 Reduced 15.75%	11,162 $2.17 Million
Q2 2020 Aug 13, 2020	SELL	$153.32 - $191.72 $1.57 Million - $1.96 Million	-10,240 Reduced 43.59%	13,249 $2.37 Million
Q1 2020 May 14, 2020	BUY	$124.34 - $193.76 $1.52 Million - $2.37 Million	12,240 Added 108.81%	23,489 $3.79 Million
Q4 2019 Feb 10, 2020	BUY	$134.81 - $177.8 $1.52 Million - $2 Million	11,249 New	11,249 $1.85 Million

373

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.09B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

Stay updated on Aviva PLC with notifications on news.